Literature DB >> 35044142

A cost-utility analysis of the impact of electronic nicotine delivery systems on health care costs and outcomes in Canada.

Catherine Pound1,2, Doug Coyle2.   

Abstract

INTRODUCTION: We determined the impact of electronic nicotine delivery systems (ENDS) on health outcomes and costs in Canada, based on their effect on smoking cessation and smoking initiation rates.
METHODS: We used gender-specific Markov models to estimate lifetime discounted life years, quality-adjusted life years (QALYs) and smoking-related health care costs for cohorts of males and females aged 15 to 19 years, in scenarios in which (1) ENDS are available (status quo); (2) ENDS are completely unavailable; and (3) ENDS are available for smoking cessation through health care provider prescription, in addition to currently recognized smoking cessation tools. Analysis was from the perspective of a publicly funded health care system.
RESULTS: Outcomes are expressed per 1000 individuals and based on expected values obtained through a Monte Carlo simulation of 10 000 replications. For males aged 15 to 19 years, life years, QALYs and smoking-related health care costs were 41 553, 35 871 and CAD 79 645 964, respectively, when ENDS were available; 41 568, 35 894 and CAD 79 645 960 when ENDS were unavailable; and 41 570, 35 897 and CAD 79 605 869 when ENDS were available through prescription only. For females, life years, QALYs and smoking-related health care costs were 43 596, 37 416 and CAD 69 242 856, respectively, when ENDS were available; 43 610, 37 438 and CAD 69 085 926 when ENDS were unavailable; and 43 611, 37 438 and CAD 69 076 034 when ENDS were available through prescription only. Thus, situations in which ENDS are unavailable, or available through prescription only are dominant over the status quo.
CONCLUSION: These results show that a policy change whereby ENDS were unavailable to the Canadian population or available through prescription only would likely increase population health and reduce health care costs.

Entities:  

Keywords:  cost-benefit analysis; electronic nicotine delivery systems; smoking; smoking cessation; tobacco products; vaping

Mesh:

Year:  2022        PMID: 35044142      PMCID: PMC9067013          DOI: 10.24095/hpcdp.42.1.05

Source DB:  PubMed          Journal:  Health Promot Chronic Dis Prev Can        ISSN: 2368-738X            Impact factor:   2.725


  30 in total

1.  The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies.

Authors:  K Claxton
Journal:  J Health Econ       Date:  1999-06       Impact factor: 3.883

Review 2.  The emerging phenomenon of electronic cigarettes.

Authors:  Pasquale Caponnetto; Davide Campagna; Gabriella Papale; Cristina Russo; Riccardo Polosa
Journal:  Expert Rev Respir Med       Date:  2012-02       Impact factor: 3.772

3.  Association of E-Cigarette Use With Respiratory Disease Among Adults: A Longitudinal Analysis.

Authors:  Dharma N Bhatta; Stanton A Glantz
Journal:  Am J Prev Med       Date:  2019-12-16       Impact factor: 5.043

4.  Estimation of smoking prevalence in Canada: Implications of survey characteristics in the CCHS and CTUMS/CTADS.

Authors:  Thierry Gagné
Journal:  Can J Public Health       Date:  2017-09-14

5.  Cost-of-illness study for non-small-cell lung cancer using real-world data.

Authors:  S J Seung; M Hurry; S Hassan; R N Walton; W K Evans
Journal:  Curr Oncol       Date:  2019-04-01       Impact factor: 3.677

6.  E-cigarette use and respiratory disorder in an adult sample.

Authors:  Thomas A Wills; Ian Pagano; Rebecca J Williams; Elizabeth K Tam
Journal:  Drug Alcohol Depend       Date:  2018-11-07       Impact factor: 4.492

7.  Quantifying population-level health benefits and harms of e-cigarette use in the United States.

Authors:  Samir S Soneji; Hai-Yen Sung; Brian A Primack; John P Pierce; James D Sargent
Journal:  PLoS One       Date:  2018-03-14       Impact factor: 3.240

8.  Development and application of an economic model (EQUIPTMOD) to assess the impact of smoking cessation.

Authors:  Kathryn Coyle; Doug Coyle; Adam Lester-George; Robert West; Bertalan Nemeth; Mickael Hiligsmann; Marta Trapero-Bertran; Reiner Leidl; Subhash Pokhrel
Journal:  Addiction       Date:  2017-09-14       Impact factor: 6.526

9.  Socioeconomic and geographic patterning of smoking behaviour in Canada: a cross-sectional multilevel analysis.

Authors:  Daniel J Corsi; Scott A Lear; Clara K Chow; S V Subramanian; Michael H Boyle; Koon K Teo
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more
  1 in total

1.  Towards a Canadian evidence base to inform action to prevent and control vaping in Canada.

Authors:  Cynthia Callard; Thierry Gagné; Jennifer L O'Loughlin
Journal:  Health Promot Chronic Dis Prev Can       Date:  2022-01       Impact factor: 2.725

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.